| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |